Supportive Care for High Cholesterol
(ALLTOP Trial)
Trial Summary
What is the purpose of this trial?
Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.
Research Team
Robert D Fishberg, MD
Principal Investigator
Atlantic Health System
Eligibility Criteria
This trial is for individuals with high cholesterol or related lipid disorders. It's aimed at those who could benefit from improved treatment access both at their primary care and specialty levels. The goal is to identify high-risk patients using electronic health records and work closely with their primary doctors for better management.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Supportive care (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Atlantic Health System
Lead Sponsor
Regeneron Pharmaceuticals
Industry Sponsor